IL2 and neoplasm: Several studies showed neoadjuvant vaccination, such as IL-2 or dendritic cell infusions, increased antitumor effectiveness of IR and resulted in an increased immune response in murine melanoma B78 tumor model or patients with soft tissue sarcoma (38, 39).